Scott Holsten

Randomized phase 2 trial of NP001, a novel immune regulator

Robert G. Miller, Gilbert Block, Jonathan Katz et al. · Neurology Neuroimmunology & Neuroinflammation · 2015 · 97 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Assessing Dysferlinopathy Patients Over Three Years With a New Motor Scale

Marni Jacobs, M. James, Linda Lowes et al. · Annals of Neurology · 2021 · 36 citations · Full text

Medicine, Neurology, Functional Movement Assessment +16

Power Wheelchair Use in Persons With Amyotrophic Lateral Sclerosis: Changes Over Time

Amber Ward, Sara Hammond, Scott Holsten et al. · Assistive Technology · 2015 · 31 citations

Medicine, Neurology, Rehabilitation Medicine +17

Assessment of disease progression in dysferlinopathy

U. Moore, Marni Jacobs, M. James et al. · Neurology · 2019 · 28 citations · Full text

Medicine, Neurology, Functional Movement Assessment +13

Six-Minute Walk Test as a Measure of Walking Capacity in Ambulatory Individuals With Amyotrophic Lateral Sclerosis

Mohammed Sanjak, Velma Langford, Scott Holsten et al. · Archives of Physical Medicine and Rehabilitation · 2017 · 22 citations

Medicine, Neurology, Rehabilitation Medicine +16